David Liberg

Membre du Conseil

BoardM

FI·FIN-FSA

Cantargia AB Cantargia AB

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Explore the full record of transactions filed by David Liberg, Membre du Conseil. Director active across 2 companies, notably Cantargia AB. Aggregated, 3 filings have been logged. The latest transaction was filed on 30 March 2026 — Purchase. Regulator: FIN-FSA. The full history is openly available.

Declarations3 total

Executives●PurchaseCCantargia AB9FIN-FSA

D

David LibergAnnan medlem i bolagets administrations-, lednings- eller kontrollorgan

080,000 shares0

Option

FI:A003X489-1·30 Mar 2026

Ideal exit: 25 Dec 2026 (T+270)

FIN-FSA ↗

Executives●PurchaseCCantargia AB17FIN-FSA

D

David LibergAnnan medlem i bolagets administrations-, lednings- eller kontrollorgan

€4,92613,000 shares@ €0.37890.0006% mcap100.0% of flow

Aktie

FI:A003X340-1·26 Mar 2026

Ideal exit: 21 Dec 2026 (T+270)

FIN-FSA ↗

Executives●PurchaseCCantargia AB9FIN-FSA

D

David LibergAnnan medlem i bolagets administrations-, lednings- eller kontrollorgan

0250,000 shares0

Option

FI:A003R856-1·29 Aug 2025

Ideal exit: 26 May 2026 (T+270)

FIN-FSA ↗

3 of 3 declarations

About David Liberg

David Liberg is a board member of Cantargia AB. He contributes to the strategic direction of the company, which focuses on developing innovative treatments for cancer. His experience in biotechnology and commitment to innovation are valuable assets for the company.